Results 21 to 30 of about 2,542 (110)

Effet hématotoxique de la consommation d'argile géophagique contaminée par des métaux lourds : étude expérimentale chez des rats Wistar (Rattus norvegicus)

open access: yesRevue des Sciences de la Santé
La géophagie, c’est-à-dire l’ingestion volontaire de sols argileux, est largement pratiquée en Afrique subsaharienne, surtout chez les femmes enceintes. Cependant, ses effets toxicologiques restent peu documentés.
Lionel S. ASAMBOA   +10 more
doaj   +1 more source

Allo-immunisation antiérythrocytaire chez les polytransfusés au Centre National Hospitalier Universitaire de Cotonou: à propos de 51 cas

open access: yesThe Pan African Medical Journal, 2021
La transfusion sanguine est un acte médical qui consiste à soigner un patient avec un produit sanguin labile. Chaque transfusion de concentré globulaire expose les receveurs à un risque d´allo-immunisation antiérythrocytaire.
Tatiana Baglo   +7 more
doaj   +1 more source

International cooperation in public health in Martinique: geostrategic utility for cancer surveillance in the Caribbean

open access: yesGlobalization and Health, 2020
Background Cooperation in public health and in oncology in particular, is currently a major issue for the island of Martinique, given its geopolitical position in the Caribbean region.
Clarisse Joachim   +15 more
doaj   +1 more source

Prise en charge des syndromes myélodysplasiques au Maroc à propos d'une étude mono-centrique

open access: yesThe Pan African Medical Journal, 2020
Il s´agit d´une étude rétrospective de type descriptive et analytique, réalisée au sein du service de l´hématologie clinique de l´hôpital militaire d´instruction Mohammed V de Rabat, étalée sur 10 ans et portant sur 76 patients dont le diagnostique de ...
Hicham El Maaroufi   +8 more
doaj   +1 more source

Development of a potency assay for CD34+ cell-based therapy

open access: yesScientific Reports, 2023
We have previously shown that intracardiac delivery of autologous CD34+ cells after acute myocardial infarction (AMI) is safe and leads to long term improvement. We are now conducting a multicenter, randomized, controlled Phase I/IIb study in post-AMI to
Anne Aries   +8 more
doaj   +1 more source

Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC network

open access: yesHaematologica, 2015
The purpose of our study is to determine the outcome of patients with systemic non-Hodgkin lymphoma presenting with neurologic localization at diagnosis, as well as the impact of consolidation in terms of high-dose therapy followed by autologous stem ...
Gandhi Damaj   +17 more
doaj   +1 more source

Outcomes of Kaposi sarcoma in people living with HIV who maintain long‐term viral suppression: A prospective case‐series

open access: yesHIV Medicine, EarlyView.
Abstract Background Data on chemotherapeutic efficacy and tolerability for Kaposi Sarcomas (KS) in people living with HIV (PWH) and HIV‐virological control are limited. We aimed to describe clinical responses and tolerability of KS therapies in PWH with HIV‐aviraemic KS in a prospective cohort.
S. Bacquart   +10 more
wiley   +1 more source

Teclistamab in relapsed refractory multiple myeloma: a multi-institutional real-world study from the French early access program

open access: yesHaematologica
Not available.
Aurore Perrot   +32 more
doaj   +1 more source

Nucleolin Alterations and ROS Production Associate With Sensitivity of AML Cells to Venetoclax

open access: yesThe FASEB Journal, Volume 40, Issue 19, 15 October 2026.
Venetoclax‐induced Bcl‐2 inhibition corresponds with Mcl‐1 attenuation and decrease of Nucleolin (NCL) level and activity in sensitive cells. Simultaneously, distinct cell subpopulations with opposite mitochondrial (CellROX label, magenta) and cellular (H2DCFDA stain, green) ROS occur, and the H2DCFDA‐positive population shows markers of early ...
Kateřina Wolfová   +2 more
wiley   +1 more source

Real‐World Evaluation of Talquetamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM): An International Myeloma Working Group Immunotherapy Registry Real‐World Analysis

open access: yesAmerican Journal of Hematology, Volume 101, Issue 8, Page 1928-1937, August 2026.
ABSTRACT Talquetamab is a GPRC5D × CD3 bispecific antibody approved for relapsed/refractory multiple myeloma (RRMM). This is the first real‐world study to comprehensively report muco‐cutaneous toxicities, infections, and efficacy of talquetamab in 151 patients across five countries with the longest follow‐up reported enabling better efficacy and ...
Murali Janakiram   +94 more
wiley   +1 more source

Home - About - Disclaimer - Privacy